Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Cofac Cooperativa de Formacao E Animacao Cultural Crl |
| Country | Portugal |
| Start Date | Jan 01, 2023 |
| End Date | Dec 31, 2026 |
| Duration | 1,460 days |
| Number of Grantees | 5 |
| Roles | Participant; Coordinator; Associated Partner |
| Data Source | European Commission |
| Grant ID | 101086453 |
Core idea of this project is to establish the mechanistic basis for the positive health effects of deuterium depleted water and determine what regimens are most efficacious.
Isotope content of drinking water has been shown affect the pathogenesis of cancers to ameliorate the stress response and reduce susceptibility to many diseases, but it remains unclear how the positive biological effects of heavy isotope reduction in drinking water are mediated.
High concentrations of deuterium induce mitochondrial dysfunction, and very high concentrations can induce cell death, but the administration of deuterium at 91 ppm has antidepressant effects that were comparable to that of citalopram in a mouse model of depression.
Use of deuterium depleted water appears to represent a safe intervention with few, if any, reported side effects, but it remains unclear at what concentrations the positive metabolic and behavioral effects become apparent.
Companies in Europe now sell DDW at different concentrations to the public amidst a plethora of health claims that mostly lack in any sound scientific basis or safety data Thus, there is an urgent need to better understand the impact of DDW on brain and behavior at a molecular level.
We will use state-of-the art imaging techniques to measure regional metabolic fluxes in the body of animals in healthy individuals throughout life and those subject to stress following the administration of DDW at different concentrations and for different periods.
Also we examine how deuterium depletion affects the behaviors of neurons in vitro and electrophysiological levels and in terms of their metabolism.
The project is made possible by bringing together a consortium of chemists, cell biologists, pharmacologists, imaging specialists, psychiatrists, and DDW producers for medicinal needs in fully translational work packages to discover, in an empiric manner, how the manipulation of metabolic pathways with DDW can be employed for the benefit of human health
Universitaetsklinikum Wuerzburg - Klinikum Der Bayerischen Julius-Maximilians-Universitat; Hyd Rakkutato Es Gyogyszerfejleszto Kft; Cofac Cooperativa de Formacao E Animacao Cultural Crl; Fundacao Gimm - Gulbenkian Institute for Molecular Medicine; The Chancellor, Masters and Scholars of the University of Oxford
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant